Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 41% ± 18% | |
epithelial cell of proximal tubule | 5 studies | 36% ± 7% | |
progenitor cell | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 95% | 1471.89 | 920 / 966 | 95% | 89.11 | 499 / 527 |
stomach | 96% | 9006.11 | 344 / 359 | 93% | 96.22 | 267 / 286 |
liver | 100% | 4559.74 | 226 / 226 | 82% | 134.84 | 331 / 406 |
pancreas | 100% | 8891.99 | 328 / 328 | 80% | 70.52 | 143 / 178 |
kidney | 100% | 2752.45 | 89 / 89 | 75% | 50.81 | 676 / 901 |
breast | 96% | 309.02 | 441 / 459 | 67% | 83.18 | 750 / 1118 |
esophagus | 79% | 77.70 | 1141 / 1445 | 50% | 49.79 | 92 / 183 |
uterus | 97% | 128.59 | 165 / 170 | 17% | 8.53 | 78 / 459 |
lung | 76% | 65.83 | 441 / 578 | 30% | 26.10 | 342 / 1155 |
ovary | 98% | 179.56 | 177 / 180 | 5% | 1.16 | 22 / 430 |
bladder | 76% | 64.05 | 16 / 21 | 27% | 23.39 | 134 / 504 |
adrenal gland | 100% | 246.38 | 258 / 258 | 2% | 0.28 | 4 / 230 |
brain | 99% | 182.27 | 2614 / 2642 | 1% | 0.18 | 9 / 705 |
thymus | 98% | 136.70 | 642 / 653 | 1% | 0.41 | 9 / 605 |
prostate | 98% | 144.24 | 239 / 245 | 0% | 0.51 | 2 / 502 |
spleen | 93% | 92.67 | 223 / 241 | 0% | 0 | 0 / 0 |
skin | 87% | 134.31 | 1580 / 1809 | 1% | 0.35 | 7 / 472 |
adipose | 86% | 107.49 | 1041 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 63% | 50.32 | 838 / 1335 | 0% | 0 | 0 / 0 |
heart | 23% | 14.00 | 201 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 30.78 | 188 / 929 | 0% | 0 | 0 / 0 |
muscle | 8% | 4.69 | 66 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 2.05 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006081 | Biological process | cellular aldehyde metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0004033 | Molecular function | aldo-keto reductase (NADPH) activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0009055 | Molecular function | electron transfer activity |
Gene name | AKR7A3 |
Protein name | Aflatoxin B1 aldehyde reductase member 3 (EC 1.-.-.-) (AFB1 aldehyde reductase 2) (AFB1-AR 2) |
Synonyms | AFAR2 |
Description | FUNCTION: Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. . |
Accessions | O95154 ENST00000361640.5 |